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Objectives: While endovascular therapy (EVT) has
increasingly become the initial intervention of choice to
treat lower extremity peripheral arterial disease, reported
outcomes for EVT in patients with critical limb ischemia
(CLI) and diabetes have been reported to be inferior com-
pared to open surgical bypass (OSB). Objective data assess-
ing the hemodynamic success of EVT compared to the
established benchmark of OSB are sparse. We therefore
evaluated and compared hemodynamic outcomes of EVT
and OSB in diabetic patients with CLI at a single academic
center.
Methods: We studied 126 consecutive patients with
diabetes and CLI who underwent either EVT (n79) or
OSB (n31) in a single center. The mean patient age was
69 years; 62% were men and 38% were women. All
patients presented with either rest pain and/or ulcer/
gangrene. Per protocol, all were assessed using ankle
brachial index (ABI), Doppler waveform analysis and
toe pressure determinations before and early post
intervention.
Results: Both EVT (	ABI & TP p0.0001) and OSB
(	ABI p0.005, TP p0.002) resulted in significant he-
modynamic improvements, with no statistically significant
initial difference between the two types of intervention
(ABI p  0.9; TP p  0.509).
Conclusions: These data suggest that with appropri-
ate patient selection, each intervention is efficacious with
respect to initial hemodynamic improvement. If the in-
termediate/long-term results of EVT for CLI in people
with diabetes are inferior, the problem is not one of
initial hemodynamic response, but more likely due to
differing patient characteristics or durability of the inter-
vention.
Hemodynamic Data: Open Surgical Bypass (OSB) versus
Endovascular Therapy (EVT)
Hemodynamic
Measurement
EVT Pre-
Intervention
EVT Post-
Intervention
Change
(Mean  SD)
Toe pressure
(TP)
35.5127.41
(N57)
63.2137.75
(N56)
31.7425.60*
(N43)
Ankle brachial
Index (ABI)
0.520.25
(N49)
0.790.28
(N53)
0.360.22**
(N37)
Hemodynamic
Measurement
OSB Pre-
Intervention
OSB Post-
Intervention
Change
(Mean  SD)
Toe pressure
(TP)
25.426.33
(N20)
52.2929.18
(N21)
35.6825.0*
(N19)
Ankle brachial
Index (ABI)
0.540.21
(N19)
0.800.24
(N15)
0.480.19**
(N12)
[(*p0.509), (**p0.9)]
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Objectives: Endovascular treatment of superficial fem-
oral artery (SFA) lesions is a well-established practice. The
repercussions of failed SFA interventions are unclear. Our
goal is to review efficacy of SFA stenting and define nega-
tive effects of its failure.
Methods: Retrospective chart review from January
2007 to January 2010 identified 42 limbs in 39 patients
that underwent SFA stenting. Follow-up ankle-brachial
index (ABI) and duplex ultrasound was performed at rou-
tine intervals.
Results: Mean patient age was 68 years (range 43-
88), 22 men (56%) and 17 women (44%). Intervention
indication was claudication in 15 (36%), rest pain in 7
(17%), tissue loss in 19 (45%). There were 15 TASC A
(36%), 9 TASC B (21%), 5 TASC C (12%), 13 TASC D
(31%) lesions. Three stents (7.7%) occluded within 30
days. 1-year primary, primary-assisted, secondary pa-
tency rates were 24%, 44%, 51% respectively. Limb sal-
vage was 93% during follow-up. Seventeen interventions
failed (40%) at 1-year. Of these, 7 (17%) developed
claudication, 7 (17%) ischemic rest pain, 3 (7%) were
asymptomatic. During follow-up, 3 (7.7%) required by-
pass and 3 (7.7%) major amputation, one following failed
bypass. All limbs requiring bypass or amputation had
TASC C/D lesions. Thirty-day mortality 2.6%. One-year
mortality 10.3%.
Conclusions: Stenting SFA lesions is technically feasi-
ble. Interventions performed for TASC C/D lesions are
more likely to fail and more likely to lead to bypass or
amputation. Interventions performed for TASC C/D le-
sions that fail have a negative impact on limb salvage. This
should be considered when performing stenting of ad-
vanced SFA lesions.
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